Press release
Hemorrhoids Market Outlook Highlights Strategic Opportunities Across The Industry
Hemorrhoids Market
Future Market Size and Growth Expectations in the Hemorrhoids Market
The hemorrhoids market is set to reach a value of $3.96 billion by 2030, growing at a steady compound annual growth rate (CAGR) of 6.2%. This expansion is largely fueled by factors such as the rising aging population, heightened emphasis on early diagnosis and treatment options, and an increasing preference for minimally invasive procedures. Additionally, the growing adoption of teleconsultation services for anorectal care and the broader availability of advanced treatment methods contribute to market growth. Important trends shaping this market include wider use of non-surgical treatments, a surge in demand for over-the-counter medications, the rise of homecare management solutions, and a stronger focus on enhancing patient comfort and recovery experiences.
The hemorrhoids market size has grown strongly in recent years. It will grow from $2.93 billion in 2025 to $3.11 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising prevalence of sedentary lifestyles, increasing incidence of chronic constipation, higher awareness of anorectal disorders, expansion of outpatient treatment facilities, availability of multiple treatment options.
Download a free sample of the hemorrhoids market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22000&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Key Companies Leading the Hemorrhoids Market Landscape
Several prominent companies play a significant role in the hemorrhoids market, including Johnson & Johnson, Bayer AG, Abbott Laboratories, Medtronic Plc, Takeda Pharmaceutical Company, Boston Scientific Corporation, Church & Dwight* Co. Inc., Dr. Reddy's Laboratories Ltd, Glenmark Pharmaceuticals, B. Braun Melsungen AG, Sebela Pharmaceuticals, Citius Pharmaceuticals, AMATO PHARMACEUTICAL PRODUCTS LTD, Surkon Medical Co. Ltd., Privi Medical, CONMED Corporation, Integra LifeSciences Corporation, Takeda Consumer Healthcare, Fresenius Kabi, and Sanofi.
In a recent development in March 2024, Sweden-based Karo Healthcare AB acquired Proctosedyl, a well-known OTC hemorrhoid treatment brand, from Bayer AG. This acquisition helps Karo Healthcare strengthen its presence in the Italian market, broaden its digestive health product portfolio, and improve consumer access to reliable hemorrhoid treatments, thereby enhancing its competitive stance in the region. Bayer AG, based in Germany, is recognized for producing OTC drugs addressing various medical conditions.
Emerging Trends Driving the Future Direction of the Hemorrhoids Market
Innovation in minimally invasive surgical products is a major focus among leading companies in the hemorrhoid market. These advanced treatment options aim to improve patient comfort, shorten recovery times, and deliver better clinical results compared to traditional surgery. Minimally invasive hemorrhoid treatments typically involve cutting-edge procedures that minimize tissue damage and pain. For instance, in December 2023, Netherlands-based Medical Fintech Innovations B.V. unveiled the HemWell GEN 2 device. This next-generation technology features the Hemwellectomy procedure, an electrosurgical solution designed as a less painful alternative to conventional hemorrhoidectomy, enabling patients to recover faster and resume daily activities sooner.
View the full hemorrhoids market report:
https://www.thebusinessresearchcompany.com/report/hemorrhoids-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Detailed Segment Breakdown of the Hemorrhoids Market
This report divides the hemorrhoids market into several key segments for a comprehensive view:
1) By Type: Internal Hemorrhoids, External Hemorrhoids, and Mixed Hemorrhoids
2) By Treatment Type: Medications, Procedures, and Surgical Treatments
3) By End User: Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), and Homecare
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
Further subcategories refine these segments as follows:
- Internal Hemorrhoids are classified into Grade I, Grade II, Grade III, and Grade IV stages.
- External Hemorrhoids are broken down into Thrombosed External Hemorrhoids and Non-Thrombosed External Hemorrhoids.
- Mixed Hemorrhoids include Combined Internal and External Hemorrhoids as well as Prolapsed Hemorrhoids.
This detailed segmentation allows for a nuanced understanding of the market's structure and offers insights into specific areas of demand and innovation within the hemorrhoids treatment landscape.
Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hemorrhoids Market Outlook Highlights Strategic Opportunities Across The Industry here
News-ID: 4608677 • Views: …
More Releases from The Business Research Company
Impetigo Market Intelligence Report Covers Trends, Segments And Regional Growth
Exploring the future outlook of the impetigo market reveals promising expansion driven by several critical healthcare trends. With a growing awareness of skin infections and advancements in treatment options, this market is set to experience significant development over the coming years.
Projected Growth and Market Size of the Impetigo Sector
The impetigo market is anticipated to reach a valuation of $3.27 billion by 2030, expanding at a compound annual growth…
Immunoglobulin A IgA Vasculitis Market Trends Support A 6.2% CAGR Outlook Throug …
Overview of the Immunoglobulin A IgA Vasculitis Market Outlook
The immunoglobulin A (IgA) vasculitis market is projected to experience significant expansion in the coming years. By 2030, its value is expected to reach $2.21 billion, growing at a compound annual growth rate (CAGR) of 6.2%. This upward trend is driven by advancements in immunomodulatory drug research, wider adoption of personalized autoimmune treatments, and increasing attention to long-term kidney protection.…
Heterozygous Familial Hypercholesterolemia Management Market Study Highlights Ho …
The management of heterozygous familial hypercholesterolemia (HeFH) is gaining significant traction as advancements in therapies and diagnostic techniques evolve. With a growing understanding of personalized cardiovascular care and innovative treatment options, the market is on track for noteworthy expansion in the near future. Here's an in-depth look at the current market size, key players, emerging trends, and segmentation insights.
Strong Growth Potential for the Heterozygous Familial Hypercholesterolemia Management Market
The…
Immune Response Testing Market Report Examines Industry Trends, Growth Drivers A …
The immune response testing market is rapidly gaining momentum as advancements in diagnostic technologies and personalized medicine continue to evolve. This sector is attracting significant attention due to its vital role in understanding immune functions across various medical fields. Let's explore the market's growth outlook, leading companies, emerging trends, and detailed segment analysis to grasp the full picture of this expanding industry.
Projected Growth and Market Size of the Immune Response…
More Releases for Hemorrhoids
Hemorrhoids Market Overview, Emerging Trends, and Key Player Analysis
The hemorrhoids market is set to experience notable expansion over the coming years, driven by advances in treatment options and growing healthcare awareness. This report delves into the anticipated market value, key players, prominent trends, and detailed segmentation shaping the industry's future.
Projected Market Value of the Hemorrhoids Industry by 2030
The hemorrhoids market is forecasted to reach a valuation of $3.96 billion by 2030, growing at a compound annual…
Hemorrhoids Market: Growth Momentum Across 7MM to 2034 - DelveInsight
The Hemorrhoids market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hemorrhoids pipeline products will significantly revolutionize the Hemorrhoids market dynamics.
DelveInsight's "Hemorrhoids Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Hemorrhoids, historical and forecasted epidemiology as well as the Hemorrhoids market trends in the United States, EU4 (Germany, Spain, Italy, France) the United…
Hemorrhoids Market Size, Share, Trends & Forecast To 2034
Market Overview:
The hemorrhoids market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical…
Mexico Hemorrhoids Treatment Market Size, Share, Industry, Forecast to 2029
The Mexico Hemorrhoids Treatment Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Mexico Hemorrhoids Treatment market. This report explores all the key factors affecting the growth of the global Mexico Hemorrhoids…
Hemorrhoids Treatment Device Market Applications, Key Players, Regions 2017-2027
Hemorrhoids are is a common condition that mainly develops at the base of the anal region. This condition employs various treatment methods that make use of specific devices
The principle of ligation with rubber bands is to encircle the base of the hemorrhoidal clump with a tight rubber band. The tissue cut off by the rubber band dies, and is replaced by an ulcer that heals with scarring.
Rubber band ligation can…
A secret problem – Taboo hemorrhoids
Often it starts with a burning sensation on the skin. This is not only painful but also embarrassing, because it appears in a very intimate place, namely in the rectum. Many people have inhibitions to talk about problems with hemorrhoids. Hemorrhoids itself are really only arteriovenous vascular pads at the end of the rectum and are necessary for safe closure of the anus. If the veins will dilate and bulge…
